A Point Mutation Associated with Bacterial Macrolide Resistance Is Present in Both 23S rRNA Genes of an Erythromycin-Resistant Treponema pallidum Clinical Isolate
Open Access
- 1 March 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (3) , 806-807
- https://doi.org/10.1128/aac.44.3.806-807.2000
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Genetic basis of macrolide and lincosamide resistance inBrachyspira(Serpulina)hyodysenteriaeFEMS Microbiology Letters, 1999
- Identification and sequence analysis ofTreponema pallidum tprJ, a member of a polymorphic multigene familyFEMS Microbiology Letters, 1998
- Complete Genome Sequence of Treponema pallidum , the Syphilis SpirocheteScience, 1998
- 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention.1998
- Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniaeAntimicrobial Agents and Chemotherapy, 1995
- In-vitro activity of azithromycin and CP-63,956 against Treponema pallidumJournal of Antimicrobial Chemotherapy, 1990
- Failure of Erythromycin to Cure Secondary Syphilis in a Patient Infected With the Human Immunodeficiency VirusArchives of Dermatology, 1989
- In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidumAntimicrobial Agents and Chemotherapy, 1988
- Erythromycin Failure in the Treatment of Syphilis in a Pregnant WomanSexually Transmitted Diseases, 1983
- Chlamydial InfectionsSexually Transmitted Diseases, 1983